These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3125634)

  • 1. Studies in small bowel transplantation. Prevention of graft-versus-host disease with preservation of allograft function by donor pretreatment with antilymphocyte serum.
    Shaffer D; Maki T; DeMichele SJ; Karlstad MD; Bistrian BR; Balogh K; Monaco AP
    Transplantation; 1988 Feb; 45(2):262-9. PubMed ID: 3125634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of graft-versus-host disease following small bowel transplantation with polyclonal and monoclonal antilymphocyte serum. The effect of timing and route of administration.
    Shaffer D; Ubhi CS; Simpson MA; Gottschalk R; Milford EL; Maki T; Monaco AP
    Transplantation; 1991 Dec; 52(6):948-52. PubMed ID: 1750080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor intrathymic injection with recipient splenocytes allows indefinite survival following small bowel transplantation in a rat graft-vs-host disease model.
    Blakely ML; Shaffer D; Ohzato H; Gottschalk R; Van der Werf WJ; Monaco AP
    Transplant Proc; 1994 Jun; 26(3):1582. PubMed ID: 8030046
    [No Abstract]   [Full Text] [Related]  

  • 4. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
    Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
    Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolongation of small bowel allografts after intrathymic injection of donor alloantigen and ALS.
    Goss JA; Nakafusa Y; Flye MW
    J Surg Res; 1993 May; 54(5):494-8. PubMed ID: 8361174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of donor pretreatment with antilymphocyte serum and cyclosporin on rejection and graft-versus-host disease after small bowel transplantation in immunosuppressed and nonimmunosuppressed rats.
    de Bruin RW; Saat RE; Heineman E; Jeekel J; Marquet RL
    Transpl Int; 1993 Jan; 6(1):22-5. PubMed ID: 8452627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of donor pretreatment on graft-versus-host disease (GVHD) after rat small-bowel transplantation (SBTX).
    Matsumoto S; Tanaka S; Orita K
    Transplant Proc; 1994 Aug; 26(4):2306-8. PubMed ID: 8066758
    [No Abstract]   [Full Text] [Related]  

  • 8. Orthotopic small bowel transplantation in rats: pretreatment of the donor with the aim of ameliorating graft-versus-host disease.
    Saat RE; de Bruin RW; Heineman E; Marquet RL; Jeekel J
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2892-3. PubMed ID: 2650393
    [No Abstract]   [Full Text] [Related]  

  • 9. Donor and recipient pretransplant conditioning with nonlethal radiation and antilymphocyte serum improves the graft survival in a rat small bowel transplant model.
    Bakonyi A; Berho M; Ruiz P; Misiakos EP; Carreno M; de Faria W; Sommariva A; Inverardi L; Miller J; Ricordi C; Tzakis AG
    Transplantation; 2001 Sep; 72(6):983-8. PubMed ID: 11579288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor pretreatment with anti-T-cell receptor monoclonal antibodies prevents graft-vs-host disease in brequinar-treated small bowel allograft recipients.
    Wang M; Stepkowski SM; Kahan BD
    Transplant Proc; 1995 Feb; 27(1):383. PubMed ID: 7879029
    [No Abstract]   [Full Text] [Related]  

  • 11. Indefinite survival following small intestinal transplantation after intrathymic injection of the donor with recipient-type splenocytes in a rat model.
    Blakely ML; Shaffer D; Ohzato H; Gottschalk R; Van der Werf WJ; Monaco AP
    Transplantation; 1995 Jan; 59(2):309-11. PubMed ID: 7839457
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of different forms of recipient antigen and different routes of antigen administration in donor pretreatment for preventing graft-versus-host disease in rat small bowel transplantation.
    He G; Wang M; Xu H; Tian L; Yu J; Stepkowski SM; Kahan BD
    Transplant Proc; 1996 Oct; 28(5):2469. PubMed ID: 8907906
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppressor cells and intrathymic inoculation of donor alloantigens in cardiac transplantation.
    Shen Z; Mohiuddin M; DiSesa VJ
    Ann Thorac Surg; 1995 Dec; 60(6):1683-5. PubMed ID: 8787463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGG-glucan, a leukocyte-specific immunostimulant, does not potentiate GVHD or allograft rejection.
    Washburn WK; Otsu I; Gottschalk R; Monaco AP
    J Surg Res; 1996 May; 62(2):179-83. PubMed ID: 8632636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of donor-specific tolerance to rat cardiac and small bowel allografts by intrathymic inoculation of donor T-cells.
    Chowdhury NC; Fawwaz RA; Oluwole SF
    J Surg Res; 1993 Apr; 54(4):368-74. PubMed ID: 8331931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of donor T cells in the tolerant rats to graft-versus-host disease by FTY720 following small bowel transplantation.
    Song J; Ito T; Matsuda C; Tanemura M; Nishida T; Nozawa M; Sawa Y
    Transplant Proc; 2006 Dec; 38(10):3181-3. PubMed ID: 17175216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lethal graft-vs-host disease after cyclosporine therapy in recipients of sensitized small bowel allografts.
    Langrehr JM; Markus PM; Lee TK; Müller AR; Banner B; Lee KK; Schraut WH
    Transplant Proc; 1992 Jun; 24(3):1138. PubMed ID: 1604556
    [No Abstract]   [Full Text] [Related]  

  • 18. The development of graft versus host disease in the immunologically compromised recipient of a small bowel allograft.
    Moynihan HL; Stangl MJ; Langrehr J; Lee KK; Banner B; Schraut WH
    Transplant Proc; 1990 Aug; 22(4):2055-7. PubMed ID: 2389520
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of antilymphocyte serum and cyclosporine on orthotopic small bowel allografts in the rat.
    Diflo T; Shaffer D; Maki T; Monaco AP
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):200-2. PubMed ID: 3258078
    [No Abstract]   [Full Text] [Related]  

  • 20. Importance of lymphoid tissue for survival of small bowel allografts.
    Pirenne J; Williams JG; Kim S; Fryer J; Benedetti E; Hakim NS; Médot M; Najarian JS; Gruessner RW; Dunn DL
    Transplant Proc; 1995 Feb; 27(1):1359-60. PubMed ID: 7878911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.